Delivery Order SPE2D020D0014-SPE2D325F273A
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Pfizer Inc. on September 25, 2025, for the supply of Premarin 25 mg vials, with a ceiling value of $1,091.08 and a completion date of September 26, 2025. This firm fixed-price delivery order was issued without a small business set-aside designation, reflecting Pfizer's status as a large-scale pharmaceutical manufacturer capable of fulfilling government medical supply requirements. The place of performance is...
- The Defense Logistics Agency awarded a $1,113 delivery order to Amerisourcebergen Drug Corporation for 4562279161 Premarin 0.3 mg tablets (100 count). The firm fixed price order is to supply 100 count bottles of the specified estrogen medication to a location in Conshohocken, Pennsylvania, with performance required between September 22 and 25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for Premarin tablets supports the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of 1,000 tablets of Premarin 0.3 mg at a ceiling value of $10,962.01. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,347.03 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Premarin 0.3 mg tablets (100 count) with a contract value of $1,695.84 and a firm fixed price structure. The delivery order, which is set to be completed by June 23, 2025, will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Premarin 25 mg vials, a hormone replacement therapy medication. This firm fixed price delivery order, valued at $4,964.60, represents a non-competitive set-aside and is scheduled for completion by September 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Premarin 0.3 mg tablets (1,000 units) with a ceiling value of $6,519.03. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is not set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) under a firm fixed-price contract valued at $1,208.97. The award, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, represents a non-set-aside competitive procurement. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, with a ceiling value of $1,417.13 and an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- SPE2D020D0014Indefinite Delivery Contract
- SPE2D020D0014-SPE2D325F273ADelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded Pfizer Inc. a delivery order valued at $1,363.85 for Premarin 25 mg vials on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order, issued under contract number 4568921941, will be performed in New York, New York and does not utilize a small business set-aside designation. Pfizer, a global pharmaceutical corporation headquartered in New York and registered as a federal contractor since 2002, serves as the prime contractor and sole awardee on this order. This delivery order represents a routine pharmaceutical procurement through the Defense Logistics Agency Troop Support's Medical Supply Chain, which manages distribution of critical medical supplies across multiple federal healthcare programs. Premarin, an estrogen-based pharmaceutical preparation, is among the diverse therapeutic products Pfizer regularly supplies to government agencies including the Department of Veterans Affairs, Department of Defense, and other federal healthcare entities. The award demonstrates Pfizer's established role as a strategic supplier of injectable medications and hormone treatments within the federal government's healthcare procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/29/25 |